Ubiquitin-Specific Protease 11-Mediated CD36 Deubiquitination Acts on C1q/TNF-Related Protein 9 Against Atherosclerosis
ESC Heart Failure · 01.08.2023 · 10 (4) · 2499-2509
DOI: 10.1002/ehf2.14423 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, online erschienen am 07.06.2023. Verfasst von Min Zeng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Center, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, P.R. China. Hauptthemen laut MEDLINE: CD36 Antigens, Atherosclerosis. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hainan Clinical Medical Research Center Project, Hainan Key R&D Plan Project, Hainan General Hospital Clinical Innovation and Transformation Cultivation 550 Project.
Abstract (Originalsprache)
Aims
Atherosclerosis is a huge threaten to the human health, C1q/TNF-related protein 9 (CTRP9) has been previously reported possessing vascular protective functions. Our study is aimed to reveal the mechanism of the regulative effects of CTRP9 on the foam cell formation. Methods and results Primary human macrophages were isolated from human monocytes donated by healthy volunteers. CCK-8 assay was performed for determining the cell viability. Oil Red O staining was employed for measuring the lipid accumulation. Cholesterol ester and cholesterol concentration were detected by commercial kits for evaluating the intracellular cholesterol. Ubiquitination assay was performed to reveal the ubiquitination level of CD36, cycloheximide assay was applied for determining the half-life of CD36 protein. Quantitative real-time PCR and western blot assays were performed for detecting the mRNA and protein expression. Pre-treatment with CTRP9 in primary human macrophages markedly suppressed the cholesterol accumulation concentration after oxidized low-density lipoprotein treatment. CD36 was significantly increased after oxidized low-density lipoprotein exposure while was reduced by CTRP9 treatment. Up-regulation of CD36 significantly reversed the CTRP9-mediated protective effects in foam cells. The differential expression levels of several deubiquitinating enzymes preliminarily indicated that USP11 was obviously decreased after CTRP9 treatment. USP11 knockdown decreased the CD36 protein expression and pre-treatment with 10 μg/mL MG132 significantly maintained the CD36 level from USP11 knock down. Up-regulation of CD36 reversed the alterations on the cholesterol metabolism caused by CTRP9 or USP11 knockdown.
Conclusions
CTRP9 regulates the USP11/CD36 axis to protect the macrophages form transforming into foam cells by suppressing intracellular lipid and cholesterol accumulation, which is a potential therapeutic agent for atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Center, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, P.R. China.
- Department of Otolaryngology, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, P.R. China.
- Hainan Medical University, Haikou, P.R. China.
Förderung
- Hainan Clinical Medical Research Center Project
- Hainan Key R&D Plan Project
- Hainan General Hospital Clinical Innovation and Transformation Cultivation 550 Project
Zitieren
APA
Zeng, M., Wei, X., He, Y., & Yang, Y. (2023). Ubiquitin-Specific Protease 11-Mediated CD36 Deubiquitination Acts on C1q/TNF-Related Protein 9 Against Atherosclerosis. ESC Heart Failure, 10(4), 2499-2509. https://doi.org/10.1002/ehf2.14423
Vancouver
Zeng M, Wei X, He Y, Yang Y. Ubiquitin-Specific Protease 11-Mediated CD36 Deubiquitination Acts on C1q/TNF-Related Protein 9 Against Atherosclerosis. ESC Heart Failure. 2023;10(4):2499-2509. doi:10.1002/ehf2.14423
BibTeX
@article{Zeng2023,
author = {Zeng, Min and Wei, Xin and He, Yangli and Yang, Yali},
title = {Ubiquitin-Specific Protease 11-Mediated CD36 Deubiquitination Acts on C1q/TNF-Related Protein 9 Against Atherosclerosis},
journal = {ESC Heart Failure},
year = {2023},
volume = {10},
number = {4},
pages = {2499--2509},
doi = {10.1002/ehf2.14423}
}
EUVIMED